FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36

FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36

Bibliografski detalji
Glavni autori:	Exley, A, Moots, R, Carruthers, D, Luqmani, R, Bacon, P
Format:	Journal article
Izdano:	1995

Slični predmeti

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
od: Bacon, P, i dr.
Izdano: (1995)

Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI).
od: Exley, A, i dr.
Izdano: (1998)

THE VASCULITIS DAMAGE INDEX (VDI)
od: Exley, A, i dr.
Izdano: (1995)

Functional outcome vs damage in systemic vasculitis
od: Exley, A, i dr.
Izdano: (1996)

Vasculitis integrated total assessment log (VITAL): A system for clinical evaluation of vasculitis.
od: Luqmani, R, i dr.
Izdano: (1996)

Cyclophosphamide and systemic vasculitis.
od: Luqmani, R, i dr.
Izdano: (1993)

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
od: Luqmani, R, i dr.
Izdano: (1994)

Damage occurs early in systemic vasculitis and is an index of outcome.
od: Exley, A, i dr.
Izdano: (1997)

Outcome in systemic vasculitis.
od: Luqmani, R, i dr.
Izdano: (1998)

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.
od: Exley, A, i dr.
Izdano: (1997)

Treatment of vasculitis in rheumatoid arthritis.
od: Luqmani, R, i dr.
Izdano: (1994)

CONTROLLED TRIAL OF PULSE VS CONTINUOUS CYCLOPHOSPHAMIDE (CY) AND PREDNISOLONE (P) IN THE TREATMENT OF SYSTEMIC VASCULITIS
od: Luqmani, R, i dr.
Izdano: (1993)

Disease assessment in systemic vasculitis
od: Luqmani, R
Izdano: (2004)

Assessment of systemic vasculitis.
od: Miller, A, i dr.
Izdano: (2008)

DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
od: Luqmani, R
Izdano: (2011)

Development of comprehensive disease assessment in systemic vasculitis.
od: Flossmann, O, i dr.
Izdano: (2007)

Development of comprehensive disease assessment in systemic vasculitis.
od: Flossmann, O, i dr.
Izdano: (2008)

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials
od: Luqmani, R, i dr.
Izdano: (2001)

Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials.
od: Luqmani, R, i dr.
Izdano: (2000)

Disease assessment and management of the vasculitides.
od: Luqmani, R, i dr.
Izdano: (1997)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
od: Mukhtyar, C, i dr.
Izdano: (2008)

Damage assessment in ANCA-associated vasculitis.
od: Bhamra, K, i dr.
Izdano: (2012)

Vasculitis: an update.
od: Luqmani, R
Izdano: (2014)

Vasculitis: an update.
od: Luqmani, R
Izdano: (2014)

Assessment of damage in vasculitis: expert ratings of damage.
od: Seo, P, i dr.
Izdano: (2009)

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
od: Lapraik, C, i dr.
Izdano: (2007)

Diagnosis and assessment of systemic vasculitis.
od: McLaren, J, i dr.
Izdano: (2002)

Discontinuation of therapies in vasculitis.
od: Luqmani, R
Izdano: (2013)

Discontinuation of therapies in vasculitis.
od: Luqmani, R
Izdano: (2013)

Discontinuation of therapies in vasculitis.
od: Luqmani, R
Izdano: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
od: Luqmani, R
Izdano: (2012)

Outpatient assessment of systemic vasculitis.
od: Nataraja, A, i dr.
Izdano: (2007)

Pharmacotherapy of vasculitis.
od: Chan, M, i dr.
Izdano: (2009)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
od: Luqmani, R, i dr.
Izdano: (2009)

Assessment of damage in vasculitis: Expert ratings of damage
od: Seo, P, i dr.
Izdano: (2008)

Assessment of the life quality of patients with multiple sclerosis using the SF-36 scale
od: N. V. Sturov, i dr.
Izdano: (2024-08-01)

Validation of a new version of the Birmingbam vasculitis activity score
od: Mukhtyar, C, i dr.
Izdano: (2008)

Relapses in patients with a systemic vasculitis.
od: Gordon, M, i dr.
Izdano: (1993)

Necrotizing vasculitis--relapse despite cytotoxic therapy.
od: Gordon, M, i dr.
Izdano: (1993)

Assessment of quality oflife in patients with early knee osteoarthritis using SF-36
od: M S Svetlova, i dr.
Izdano: (2007-10-01)